Vulvovaginal candidiasis in Iranian women: Molecular identification and antifungal susceptibility pattern

Aim Vulvovaginal candidiasis (VVC), is a common fungal infection that remains a global concern. The objectives of this study were molecular identification and assessment of the antifungal susceptibility profile of Candida species, causing VVC in southeast Iran. Methods A cross‐sectional investigatio...

Full description

Saved in:
Bibliographic Details
Published inThe journal of obstetrics and gynaecology research Vol. 48; no. 12; pp. 3292 - 3303
Main Authors Khaksar Baniasadi, Ali, Ayatollahi Mosavi, Seyyed Amin, Sharifi, Iraj, Bamorovat, Mehdi, Salari, Samira, Ahmadi, Atefeh, Amanizadeh, Azam, Agha Kuchak Afshari, Setareh
Format Journal Article
LanguageEnglish
Published Kyoto, Japan John Wiley & Sons Australia, Ltd 01.12.2022
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN1341-8076
1447-0756
1447-0756
DOI10.1111/jog.15442

Cover

Abstract Aim Vulvovaginal candidiasis (VVC), is a common fungal infection that remains a global concern. The objectives of this study were molecular identification and assessment of the antifungal susceptibility profile of Candida species, causing VVC in southeast Iran. Methods A cross‐sectional investigation was carried out on 119 nonpregnant females suspected of VVC between February 2019 and May 2021. Yeast samples were characterized to the species level by conventional and molecular methods. All Candida isolates were examined for in vitro susceptibility profile to six conventional antifungal drugs using Clinical and Laboratory Standards Institute guidelines. Results Out of 119 subjects, 52 (43.7%) cases were affected by VVC, out of whom 11 (21.15%) cases had recurrent vulvovaginal candidiasis (RVVC). The species distribution was as follows; Candida albicans (n = 21; 40.4%), C. glabrata (n = 11; 21.2%), C. tropicalis (n = 9; 17.3%), C. parapsilosis (n = 5; 9.7%), C. africana (n = 3; 5.7%), C. famata (n = 1; 1.9%), C. lusitaniae (n = 1; 1.9%), and C. dubliniensis (n = 1; 1.9%). The resistance rate of Candida isolates to fluconazole, itraconazole, and voriconazole were 15.38%, 11.5%, and 3.8%, respectively. Resistance to fluconazole was obtained in 46% (5/11) of RVVC cases but only in 7% (3/41) of VVC cases. Conclusion This study demonstrated that the majority of VVC cases were caused by non‐albicans Candida species which also were resistant to some antifungal agents. Hence, our findings revealed the importance of conducting periodical epidemiological studies to determine changes in species distribution. Moreover, for effective management of treatment and infection, it is imperative to evaluate the susceptibility profiles of Candida species isolated from VVC patients.
AbstractList AimVulvovaginal candidiasis (VVC), is a common fungal infection that remains a global concern. The objectives of this study were molecular identification and assessment of the antifungal susceptibility profile of Candida species, causing VVC in southeast Iran.MethodsA cross‐sectional investigation was carried out on 119 nonpregnant females suspected of VVC between February 2019 and May 2021. Yeast samples were characterized to the species level by conventional and molecular methods. All Candida isolates were examined for in vitro susceptibility profile to six conventional antifungal drugs using Clinical and Laboratory Standards Institute guidelines.ResultsOut of 119 subjects, 52 (43.7%) cases were affected by VVC, out of whom 11 (21.15%) cases had recurrent vulvovaginal candidiasis (RVVC). The species distribution was as follows; Candida albicans (n = 21; 40.4%), C. glabrata (n = 11; 21.2%), C. tropicalis (n = 9; 17.3%), C. parapsilosis (n = 5; 9.7%), C. africana (n = 3; 5.7%), C. famata (n = 1; 1.9%), C. lusitaniae (n = 1; 1.9%), and C. dubliniensis (n = 1; 1.9%). The resistance rate of Candida isolates to fluconazole, itraconazole, and voriconazole were 15.38%, 11.5%, and 3.8%, respectively. Resistance to fluconazole was obtained in 46% (5/11) of RVVC cases but only in 7% (3/41) of VVC cases.ConclusionThis study demonstrated that the majority of VVC cases were caused by non‐albicans Candida species which also were resistant to some antifungal agents. Hence, our findings revealed the importance of conducting periodical epidemiological studies to determine changes in species distribution. Moreover, for effective management of treatment and infection, it is imperative to evaluate the susceptibility profiles of Candida species isolated from VVC patients.
Aim Vulvovaginal candidiasis (VVC), is a common fungal infection that remains a global concern. The objectives of this study were molecular identification and assessment of the antifungal susceptibility profile of Candida species, causing VVC in southeast Iran. Methods A cross‐sectional investigation was carried out on 119 nonpregnant females suspected of VVC between February 2019 and May 2021. Yeast samples were characterized to the species level by conventional and molecular methods. All Candida isolates were examined for in vitro susceptibility profile to six conventional antifungal drugs using Clinical and Laboratory Standards Institute guidelines. Results Out of 119 subjects, 52 (43.7%) cases were affected by VVC, out of whom 11 (21.15%) cases had recurrent vulvovaginal candidiasis (RVVC). The species distribution was as follows; Candida albicans (n = 21; 40.4%), C. glabrata (n = 11; 21.2%), C. tropicalis (n = 9; 17.3%), C. parapsilosis (n = 5; 9.7%), C. africana (n = 3; 5.7%), C. famata (n = 1; 1.9%), C. lusitaniae (n = 1; 1.9%), and C. dubliniensis (n = 1; 1.9%). The resistance rate of Candida isolates to fluconazole, itraconazole, and voriconazole were 15.38%, 11.5%, and 3.8%, respectively. Resistance to fluconazole was obtained in 46% (5/11) of RVVC cases but only in 7% (3/41) of VVC cases. Conclusion This study demonstrated that the majority of VVC cases were caused by non‐albicans Candida species which also were resistant to some antifungal agents. Hence, our findings revealed the importance of conducting periodical epidemiological studies to determine changes in species distribution. Moreover, for effective management of treatment and infection, it is imperative to evaluate the susceptibility profiles of Candida species isolated from VVC patients.
Vulvovaginal candidiasis (VVC), is a common fungal infection that remains a global concern. The objectives of this study were molecular identification and assessment of the antifungal susceptibility profile of Candida species, causing VVC in southeast Iran.AIMVulvovaginal candidiasis (VVC), is a common fungal infection that remains a global concern. The objectives of this study were molecular identification and assessment of the antifungal susceptibility profile of Candida species, causing VVC in southeast Iran.A cross-sectional investigation was carried out on 119 nonpregnant females suspected of VVC between February 2019 and May 2021. Yeast samples were characterized to the species level by conventional and molecular methods. All Candida isolates were examined for in vitro susceptibility profile to six conventional antifungal drugs using Clinical and Laboratory Standards Institute guidelines.METHODSA cross-sectional investigation was carried out on 119 nonpregnant females suspected of VVC between February 2019 and May 2021. Yeast samples were characterized to the species level by conventional and molecular methods. All Candida isolates were examined for in vitro susceptibility profile to six conventional antifungal drugs using Clinical and Laboratory Standards Institute guidelines.Out of 119 subjects, 52 (43.7%) cases were affected by VVC, out of whom 11 (21.15%) cases had recurrent vulvovaginal candidiasis (RVVC). The species distribution was as follows; Candida albicans (n = 21; 40.4%), C. glabrata (n = 11; 21.2%), C. tropicalis (n = 9; 17.3%), C. parapsilosis (n = 5; 9.7%), C. africana (n = 3; 5.7%), C. famata (n = 1; 1.9%), C. lusitaniae (n = 1; 1.9%), and C. dubliniensis (n = 1; 1.9%). The resistance rate of Candida isolates to fluconazole, itraconazole, and voriconazole were 15.38%, 11.5%, and 3.8%, respectively. Resistance to fluconazole was obtained in 46% (5/11) of RVVC cases but only in 7% (3/41) of VVC cases.RESULTSOut of 119 subjects, 52 (43.7%) cases were affected by VVC, out of whom 11 (21.15%) cases had recurrent vulvovaginal candidiasis (RVVC). The species distribution was as follows; Candida albicans (n = 21; 40.4%), C. glabrata (n = 11; 21.2%), C. tropicalis (n = 9; 17.3%), C. parapsilosis (n = 5; 9.7%), C. africana (n = 3; 5.7%), C. famata (n = 1; 1.9%), C. lusitaniae (n = 1; 1.9%), and C. dubliniensis (n = 1; 1.9%). The resistance rate of Candida isolates to fluconazole, itraconazole, and voriconazole were 15.38%, 11.5%, and 3.8%, respectively. Resistance to fluconazole was obtained in 46% (5/11) of RVVC cases but only in 7% (3/41) of VVC cases.This study demonstrated that the majority of VVC cases were caused by non-albicans Candida species which also were resistant to some antifungal agents. Hence, our findings revealed the importance of conducting periodical epidemiological studies to determine changes in species distribution. Moreover, for effective management of treatment and infection, it is imperative to evaluate the susceptibility profiles of Candida species isolated from VVC patients.CONCLUSIONThis study demonstrated that the majority of VVC cases were caused by non-albicans Candida species which also were resistant to some antifungal agents. Hence, our findings revealed the importance of conducting periodical epidemiological studies to determine changes in species distribution. Moreover, for effective management of treatment and infection, it is imperative to evaluate the susceptibility profiles of Candida species isolated from VVC patients.
Author Khaksar Baniasadi, Ali
Agha Kuchak Afshari, Setareh
Amanizadeh, Azam
Salari, Samira
Ahmadi, Atefeh
Ayatollahi Mosavi, Seyyed Amin
Sharifi, Iraj
Bamorovat, Mehdi
Author_xml – sequence: 1
  givenname: Ali
  surname: Khaksar Baniasadi
  fullname: Khaksar Baniasadi, Ali
  organization: Kerman University of Medical Sciences
– sequence: 2
  givenname: Seyyed Amin
  surname: Ayatollahi Mosavi
  fullname: Ayatollahi Mosavi, Seyyed Amin
  organization: Kerman University of Medical Sciences
– sequence: 3
  givenname: Iraj
  orcidid: 0000-0002-6894-6834
  surname: Sharifi
  fullname: Sharifi, Iraj
  organization: Kerman University of Medical Sciences
– sequence: 4
  givenname: Mehdi
  orcidid: 0000-0002-4900-4278
  surname: Bamorovat
  fullname: Bamorovat, Mehdi
  organization: Kerman University of Medical Sciences
– sequence: 5
  givenname: Samira
  surname: Salari
  fullname: Salari, Samira
  organization: Kerman University of Medical Sciences
– sequence: 6
  givenname: Atefeh
  surname: Ahmadi
  fullname: Ahmadi, Atefeh
  organization: Kerman University of Medical Sciences
– sequence: 7
  givenname: Azam
  surname: Amanizadeh
  fullname: Amanizadeh, Azam
  organization: Kerman University of Medical Sciences
– sequence: 8
  givenname: Setareh
  orcidid: 0000-0003-2978-9095
  surname: Agha Kuchak Afshari
  fullname: Agha Kuchak Afshari, Setareh
  email: afshari_setareh@yahoo.com
  organization: Kerman University of Medical Sciences
BookMark eNp1kE9PwyAYh4nRxPnn4Ddo4kUPVSiltN6M0Tkz40W9NpTC8i4MJtAt-_Yyt5NREgIhz_PLy-8EHVpnFUIXBN-QtG7nbnZDWFkWB2hEypLnmLPqMN1pSfIa8-oYnYQwx5jwhtQjBJ-DWbmVmIEVJpPC9tCDCBAysNnECwvCZmu3UPYue3VGycEIn0GvbAQNUkRwNktW2ulhsLOUEoYg1TJCBwbiJluKGJW3Z-hICxPU-f48RR9Pj-8Pz_n0bTx5uJ_mkrKyyHnHO10RyVjHeq6JUFKWohFaYSo1JzUtGsU7RaueYV1zSigjum_qjlS1ZpSeoqtd7tK7r0GF2C4gzWOMsMoNoS14gZuC4bpO6OUvdO4Gn4rYUiXlFa34NvB2R0nvQvBKtxLiz8ejF2Bagttt9cmdtT_VJ-P6l7H0sBB-8ye7T1-DUZv_wfblbbwzvgERW5b3
CitedBy_id crossref_primary_10_1186_s41512_024_00180_6
crossref_primary_10_3390_jof9121159
crossref_primary_10_1016_j_diagmicrobio_2024_116606
crossref_primary_10_3390_jof11010005
crossref_primary_10_1177_09564624241296582
Cites_doi 10.1016/j.heliyon.2020.e03619
10.1093/genetics/iyaa004
10.1093/cid/civ933
10.1007/s11908-010-0137-9
10.4314/ahs.v14i4.10
10.1097/AOG.0b013e31827307b2
10.1016/j.ram.2015.10.003
10.5812/jjm.8(4)2015.15992
10.1111/myc.12204
10.5812/jjm.56117
10.1016/j.mycmed.2020.100968
10.1016/j.jiac.2015.08.008
10.1186/s12905-018-0607-z
10.3314/jjmm.47.225
10.1089/mdr.2020.0139
10.5812/jjm.113716
10.1016/j.micpath.2021.104802
10.1007/s11046-010-9388-0
10.1016/j.diagmicrobio.2008.05.014
10.3390/jof8010014
10.1016/j.mycmed.2014.10.021
10.1186/1477-7525-11-169
10.2478/rrlm-2021-0012
10.1016/j.micpath.2020.104471
10.3390/jof5040117
10.1016/j.mimet.2015.02.004
10.1111/aji.12811
10.1128/JCM.02363-09
10.1016/j.cmi.2019.03.028
10.1111/myc.13280
10.1155/2018/9703754
10.1111/jog.15267
10.1016/j.genrep.2019.100484
10.1016/S0140-6736(07)60917-9
10.1371/journal.pone.0237046
10.1016/j.micpath.2018.12.028
10.1111/j.1439-0507.2009.01752.x
10.1007/s11046-021-00556-y
10.1186/s12879-020-04985-w
10.1007/s11046-018-0305-2
10.3390/jof6010027
10.1016/S1473-3099(18)30103-8
10.3389/fpubh.2018.00078
10.1111/myc.12946
ContentType Journal Article
Copyright 2022 Japan Society of Obstetrics and Gynecology.
2022 Japan Society of Obstetrics and Gynecology
Copyright_xml – notice: 2022 Japan Society of Obstetrics and Gynecology.
– notice: 2022 Japan Society of Obstetrics and Gynecology
DBID AAYXX
CITATION
7T5
7TO
H94
K9.
7X8
DOI 10.1111/jog.15442
DatabaseName CrossRef
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts

MEDLINE - Academic
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1447-0756
EndPage 3303
ExternalDocumentID 10_1111_jog_15442
JOG15442
Genre article
GeographicLocations Iran
GeographicLocations_xml – name: Iran
GrantInformation_xml – fundername: Kerman University of Medical Sciences
  funderid: 98000762
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OB
1OC
29L
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
ZZTAW
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
AIQQE
CITATION
7T5
7TO
H94
K9.
7X8
ID FETCH-LOGICAL-c3542-7b7bf61c55b5d7f1aecc4a9afe03cf718329e7be36d50f8731351fd98b168f533
IEDL.DBID DR2
ISSN 1341-8076
1447-0756
IngestDate Fri Jul 11 16:05:43 EDT 2025
Tue Oct 07 06:56:19 EDT 2025
Wed Oct 01 03:13:01 EDT 2025
Thu Apr 24 23:05:57 EDT 2025
Wed Jan 22 16:21:08 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3542-7b7bf61c55b5d7f1aecc4a9afe03cf718329e7be36d50f8731351fd98b168f533
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-6894-6834
0000-0002-4900-4278
0000-0003-2978-9095
PQID 2743763673
PQPubID 2045132
PageCount 12
ParticipantIDs proquest_miscellaneous_2720925088
proquest_journals_2743763673
crossref_citationtrail_10_1111_jog_15442
crossref_primary_10_1111_jog_15442
wiley_primary_10_1111_jog_15442_JOG15442
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate December 2022
2022-12-00
20221201
PublicationDateYYYYMMDD 2022-12-01
PublicationDate_xml – month: 12
  year: 2022
  text: December 2022
PublicationDecade 2020
PublicationPlace Kyoto, Japan
PublicationPlace_xml – name: Kyoto, Japan
– name: Hoboken
PublicationTitle The journal of obstetrics and gynaecology research
PublicationYear 2022
Publisher John Wiley & Sons Australia, Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons Australia, Ltd
– name: Wiley Subscription Services, Inc
References 2010; 12
2021; 8
2021; 27
2012; 120
2021; 64
2007; 369
2019; 5
2020; 20
2021; 29
2019; 12
2020; 148
2019; 17
2020; 15
2011; 54
2022; 48
2021; 186
2019; 128
2019; 184
2018; 22
2015; 8
2011; 171
2021; 14
2018; 6
2018; 18
2020; 6
2015; 25
2018; 2018
2010; 48
2019; 62
2013; 11
2020; 30
2021
2015; 111
2017; 10
2006; 47
2021; 217
2019; 25
2022; 14
2014; 14
2014; 57
2016; 62
2021; 154
2008; 62
2016; 48
2018; 79
2016; 22
e_1_2_8_28_1
Faridi A (e_1_2_8_23_1) 2022; 14
e_1_2_8_24_1
e_1_2_8_47_1
e_1_2_8_26_1
e_1_2_8_49_1
e_1_2_8_3_1
e_1_2_8_5_1
e_1_2_8_7_1
e_1_2_8_9_1
e_1_2_8_20_1
e_1_2_8_43_1
e_1_2_8_22_1
e_1_2_8_45_1
Zeng X (e_1_2_8_25_1) 2018; 2018
e_1_2_8_41_1
e_1_2_8_17_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_15_1
e_1_2_8_38_1
e_1_2_8_32_1
e_1_2_8_11_1
e_1_2_8_30_1
Jeanmonod R (e_1_2_8_2_1) 2021
e_1_2_8_46_1
e_1_2_8_27_1
e_1_2_8_48_1
Nejat ZA (e_1_2_8_29_1) 2018; 22
Kiasat N (e_1_2_8_34_1) 2019; 12
e_1_2_8_4_1
e_1_2_8_6_1
e_1_2_8_8_1
e_1_2_8_21_1
e_1_2_8_42_1
e_1_2_8_44_1
Hashemi SE (e_1_2_8_35_1) 2019; 5
e_1_2_8_40_1
e_1_2_8_18_1
e_1_2_8_39_1
e_1_2_8_14_1
e_1_2_8_16_1
e_1_2_8_37_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_50_1
References_xml – volume: 111
  start-page: 50
  year: 2015
  end-page: 6
  article-title: Current methods for identifying clinically important cryptic Candida species
  publication-title: J Microbiol Methods
– volume: 154
  year: 2021
  article-title: Vulvovaginal candidiasis in Iran: a systematic review and meta‐analysis on the epidemiology, clinical manifestations, demographic characteristics, risk factors, etiologic agents and laboratory diagnosis
  publication-title: Microb Pathog
– volume: 217
  issue: 2
  year: 2021
  article-title: Extreme diversification driven by parallel events of massive loss of heterozygosity in the hybrid lineage of Candida albicans
  publication-title: Genetics
– volume: 8
  start-page: 14
  issue: 1
  year: 2021
  article-title: Antifungal resistance in clinical isolates of Candida glabrata in Ibero‐America
  publication-title: J Fungi (Basel)
– volume: 128
  start-page: 13
  year: 2019
  end-page: 9
  article-title: Correlation between antifungal resistance and virulence factors in Candida albicans recovered from vaginal specimens
  publication-title: Microb Pathog
– volume: 369
  start-page: 1961
  issue: 9577
  year: 2007
  end-page: 71
  article-title: Vulvovaginal candidosis
  publication-title: Lancet
– volume: 48
  start-page: 43
  issue: 1
  year: 2016
  end-page: 9
  article-title: Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina
  publication-title: Rev Argent Microbiol
– volume: 14
  start-page: 423
  issue: 3
  year: 2022
  end-page: 9
  article-title: Molecular discrimination and antifungal susceptibility profile of cryptic Candida albicans complex species isolated from patients in Iran
  publication-title: Iran J Microbiol
– volume: 18
  start-page: 1
  issue: 1
  year: 2018
  end-page: 10
  article-title: Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
  publication-title: BMC Womens Health
– volume: 57
  start-page: 584
  issue: 10
  year: 2014
  end-page: 91
  article-title: Vulvovaginal candidiasis: species distribution, fluconazole resistance and drug efflux pump gene overexpression
  publication-title: Mycoses
– year: 2021
– volume: 8
  issue: 4
  year: 2015
  article-title: Isolation of different species of Candida in patients with vulvovaginal candidiasis from Sari, Iran
  publication-title: Jundishapur J Microbiol
– volume: 6
  issue: 3
  year: 2020
  article-title: Low prevalence of antifungal resistant Candida africana, in the C. albicans complex causing vulvovaginal candidiasis
  publication-title: Heliyon
– volume: 64
  start-page: 771
  issue: 7
  year: 2021
  end-page: 9
  article-title: Molecular identification and antifungal susceptibility profiles of Candida dubliniensis and Candida africana isolated from vulvovaginal candidiasis: a single‐centre experience in Iran
  publication-title: Mycoses
– volume: 184
  start-page: 413
  issue: 3
  year: 2019
  end-page: 22
  article-title: Antifungal susceptibility profile of Candida albicans isolated from vulvovaginal candidiasis in Xinjiang province of China
  publication-title: Mycopathologia
– volume: 11
  start-page: 169
  year: 2013
  article-title: Subjective health status and health‐related quality of life among women with recurrent vulvovaginal candidosis (RVVC) in Europe and the USA
  publication-title: Health Qual Life Outcomes
– volume: 54
  start-page: 34
  issue: 1
  year: 2011
  end-page: 8
  article-title: Susceptibility profile of vaginal isolates of Candida albicans prior to and following fluconazole introduction–impact of two decades
  publication-title: Mycoses
– volume: 25
  start-page: 792
  issue: 7
  year: 2019
  end-page: 8
  article-title: Resistance of Candida to azoles and echinocandins worldwide
  publication-title: Clin Microbiol Infect
– volume: 2018
  start-page: 1
  year: 2018
  end-page: 8
  article-title: Risk factors of vulvovaginal candidiasis among women of reproductive age in Xi'an: a cross‐sectional study
  publication-title: Biomed Res Int
– volume: 48
  start-page: 1270
  issue: 4
  year: 2010
  end-page: 5
  article-title: Antifungal susceptibility testing of Candida isolates from the Candida surveillance study
  publication-title: J Clin Microbiol
– volume: 22
  start-page: 33
  issue: 1
  year: 2018
  article-title: Molecular identification and antifungal susceptibility pattern of non‐albicans Candida species isolated from vulvovaginal candidiasis
  publication-title: Iran Biomed J
– volume: 15
  issue: 8
  year: 2020
  article-title: Distribution, antifungal susceptibility pattern and intra‐Candida albicans species complex prevalence of Candida africana: a systematic review and meta‐analysis
  publication-title: PLoS One
– volume: 148
  year: 2020
  article-title: Recurrent vulvovaginal Candida spp isolates phenotypically express less virulence traits
  publication-title: Microb Pathog
– volume: 6
  start-page: 78
  year: 2018
  article-title: Vaginal microbiomes associated with aerobic vaginitis and bacterial vaginosis
  publication-title: Front Public Health
– volume: 27
  start-page: 1087
  issue: 8
  year: 2021
  end-page: 95
  article-title: Species distribution and antifungal susceptibility profiles of isolates from women with nonrecurrent and recurrent vulvovaginal candidiasis
  publication-title: Microb Drug Resist
– volume: 5
  start-page: 26
  issue: 4
  year: 2019
  end-page: 34
  article-title: Species distribution and susceptibility profiles of Candida species isolated from vulvovaginal candidiasis, emergence of C. lusitaniae
  publication-title: Curr Med Mycol
– volume: 120
  start-page: 1407
  issue: 6
  year: 2012
  end-page: 14
  article-title: Fluconazole‐resistant Candida albicans vulvovaginitis
  publication-title: Obstet Gynecol
– volume: 47
  start-page: 225
  issue: 3
  year: 2006
  end-page: 9
  article-title: A one‐enzyme PCR‐RFLP assay for identification of six medically important Candida species
  publication-title: Nippon Ishinkin Gakkai Zasshi
– volume: 20
  start-page: 1
  issue: 1
  year: 2020
  end-page: 10
  article-title: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
  publication-title: BMC Infect Dis
– volume: 14
  issue: 1
  year: 2021
  article-title: Genetic analysis of Candida glabrata from Candiduric patients using microsatellite length polymorphism, antifungal susceptibility, and enzymatic profiles
  publication-title: Jundishapur J Microbiol
– volume: 79
  issue: 4
  year: 2018
  article-title: Is non‐response to fluconazole maintenance therapy for recurrent Candida vaginitis related to sensitization to atopic reactions?
  publication-title: Am J Reprod Immunol
– volume: 186
  start-page: 411
  issue: 3
  year: 2021
  end-page: 21
  article-title: Difference between the profiles presented by yeasts that colonize the vaginal mucosa or cause primary or recurrent candidiasis
  publication-title: Mycopathologia
– volume: 12
  start-page: 465
  issue: 6
  year: 2010
  end-page: 70
  article-title: Vulvovaginal candidiasis caused by non‐albicans Candida species: new insights
  publication-title: Curr Infect Dis Rep
– volume: 30
  issue: 3
  year: 2020
  article-title: Comparative in vitro activities of seven antifungal drugs against clinical isolates of Candida parapsilosis complex
  publication-title: J Mycol Med
– volume: 17
  year: 2019
  article-title: Molecular identification of Candida species, assessment of the antifungal susceptibility and the genetic relationship of Candida albicans isolated from immunocompromised patients in Kerman, Iran
  publication-title: Gene Rep
– volume: 48
  start-page: 1546
  year: 2022
  end-page: 60
  article-title: Vulvovaginal candidiasis: An overview of mycological, clinical, and immunological aspects
  publication-title: J Obstet Gynaecol Res
– volume: 62
  start-page: 692
  issue: 8
  year: 2019
  end-page: 7
  article-title: Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis
  publication-title: Mycoses
– volume: 14
  start-page: 835
  issue: 4
  year: 2014
  end-page: 9
  article-title: Risk factors for candida infection of the genital tract in the tropics
  publication-title: Afr Health Sci
– volume: 10
  issue: 12
  year: 2017
  article-title: Multicenter identification and antifungal susceptibility patterns of candida species isolated from clinical samples
  publication-title: Jundishapur J Microbiol
– volume: 62
  start-page: 230
  issue: 2
  year: 2008
  end-page: 3
  article-title: First molecular method for discriminating between Candida africana, Candida albicans, and Candida dubliniensis by using hwp1 gene
  publication-title: Diagn Microbiol Infect Dis
– volume: 6
  start-page: 27
  issue: 1
  year: 2020
  article-title: Vulvovaginal candidiasis: a current understanding and burning questions
  publication-title: J Fungi (Basel)
– volume: 62
  start-page: e1
  issue: 4
  year: 2016
  end-page: e50
  article-title: Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America
  publication-title: Clin Infect Dis
– volume: 25
  start-page: 23
  issue: 1
  year: 2015
  end-page: 8
  article-title: Species spectrum and antifungal susceptibility profile of vaginal isolates of Candida in Kuwait
  publication-title: J Mycol Med
– volume: 171
  start-page: 417
  issue: 6
  year: 2011
  end-page: 22
  article-title: Antifungal susceptibility of bloodstream Candida isolates in Sfax hospital: Tunisia
  publication-title: Mycopathologia
– volume: 18
  start-page: e339
  issue: 11
  year: 2018
  end-page: e47
  article-title: Global burden of recurrent vulvovaginal candidiasis: a systematic review
  publication-title: Lancet Infect Dis
– volume: 29
  start-page: 201
  issue: 2
  year: 2021
  end-page: 15
  article-title: Vaginal candidiasis in Konya area: etiology, risk factors, virulence patterns, and antifungal susceptibility
  publication-title: Rev Rom Med Lab
– volume: 22
  start-page: 124
  issue: 2
  year: 2016
  end-page: 6
  article-title: Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis
  publication-title: J Infect Chemother
– volume: 5
  start-page: 117
  issue: 4
  year: 2019
  article-title: Identification of cryptic species of four Candida complexes in a culture collection
  publication-title: J Fungi (Basel)
– volume: 12
  start-page: 1
  issue: 3
  year: 2019
  end-page: 6
  article-title: Prevalence of vulvovaginal candidiasis in Ahvaz, Southwest Iran: a semi‐large scale study
  publication-title: Jundishapur J Microbiol
– ident: e_1_2_8_38_1
  doi: 10.1016/j.heliyon.2020.e03619
– ident: e_1_2_8_12_1
  doi: 10.1093/genetics/iyaa004
– ident: e_1_2_8_17_1
  doi: 10.1093/cid/civ933
– ident: e_1_2_8_8_1
  doi: 10.1007/s11908-010-0137-9
– ident: e_1_2_8_26_1
  doi: 10.4314/ahs.v14i4.10
– ident: e_1_2_8_19_1
  doi: 10.1097/AOG.0b013e31827307b2
– ident: e_1_2_8_39_1
  doi: 10.1016/j.ram.2015.10.003
– volume: 14
  start-page: 423
  issue: 3
  year: 2022
  ident: e_1_2_8_23_1
  article-title: Molecular discrimination and antifungal susceptibility profile of cryptic Candida albicans complex species isolated from patients in Iran
  publication-title: Iran J Microbiol
– ident: e_1_2_8_30_1
  doi: 10.5812/jjm.8(4)2015.15992
– volume: 5
  start-page: 26
  issue: 4
  year: 2019
  ident: e_1_2_8_35_1
  article-title: Species distribution and susceptibility profiles of Candida species isolated from vulvovaginal candidiasis, emergence of C. lusitaniae
  publication-title: Curr Med Mycol
– ident: e_1_2_8_16_1
  doi: 10.1111/myc.12204
– ident: e_1_2_8_45_1
  doi: 10.5812/jjm.56117
– ident: e_1_2_8_14_1
  doi: 10.1016/j.mycmed.2020.100968
– ident: e_1_2_8_44_1
  doi: 10.1016/j.jiac.2015.08.008
– ident: e_1_2_8_36_1
  doi: 10.1186/s12905-018-0607-z
– ident: e_1_2_8_22_1
  doi: 10.3314/jjmm.47.225
– ident: e_1_2_8_33_1
  doi: 10.1089/mdr.2020.0139
– ident: e_1_2_8_47_1
  doi: 10.5812/jjm.113716
– ident: e_1_2_8_21_1
  doi: 10.1016/j.micpath.2021.104802
– ident: e_1_2_8_46_1
  doi: 10.1007/s11046-010-9388-0
– ident: e_1_2_8_24_1
  doi: 10.1016/j.diagmicrobio.2008.05.014
– ident: e_1_2_8_20_1
  doi: 10.3390/jof8010014
– ident: e_1_2_8_40_1
  doi: 10.1016/j.mycmed.2014.10.021
– ident: e_1_2_8_27_1
  doi: 10.1186/1477-7525-11-169
– volume-title: Vaginal candidiasis
  year: 2021
  ident: e_1_2_8_2_1
– volume: 12
  start-page: 1
  issue: 3
  year: 2019
  ident: e_1_2_8_34_1
  article-title: Prevalence of vulvovaginal candidiasis in Ahvaz, Southwest Iran: a semi‐large scale study
  publication-title: Jundishapur J Microbiol
– ident: e_1_2_8_50_1
  doi: 10.2478/rrlm-2021-0012
– ident: e_1_2_8_28_1
  doi: 10.1016/j.micpath.2020.104471
– ident: e_1_2_8_9_1
  doi: 10.3390/jof5040117
– ident: e_1_2_8_10_1
  doi: 10.1016/j.mimet.2015.02.004
– ident: e_1_2_8_18_1
  doi: 10.1111/aji.12811
– ident: e_1_2_8_49_1
  doi: 10.1128/JCM.02363-09
– ident: e_1_2_8_13_1
  doi: 10.1016/j.cmi.2019.03.028
– ident: e_1_2_8_37_1
  doi: 10.1111/myc.13280
– volume: 2018
  start-page: 1
  year: 2018
  ident: e_1_2_8_25_1
  article-title: Risk factors of vulvovaginal candidiasis among women of reproductive age in Xi'an: a cross‐sectional study
  publication-title: Biomed Res Int
  doi: 10.1155/2018/9703754
– ident: e_1_2_8_31_1
  doi: 10.1111/jog.15267
– ident: e_1_2_8_42_1
  doi: 10.1016/j.genrep.2019.100484
– ident: e_1_2_8_3_1
  doi: 10.1016/S0140-6736(07)60917-9
– ident: e_1_2_8_11_1
  doi: 10.1371/journal.pone.0237046
– ident: e_1_2_8_43_1
  doi: 10.1016/j.micpath.2018.12.028
– ident: e_1_2_8_15_1
  doi: 10.1111/j.1439-0507.2009.01752.x
– ident: e_1_2_8_32_1
  doi: 10.1007/s11046-021-00556-y
– volume: 22
  start-page: 33
  issue: 1
  year: 2018
  ident: e_1_2_8_29_1
  article-title: Molecular identification and antifungal susceptibility pattern of non‐albicans Candida species isolated from vulvovaginal candidiasis
  publication-title: Iran Biomed J
– ident: e_1_2_8_7_1
  doi: 10.1186/s12879-020-04985-w
– ident: e_1_2_8_41_1
  doi: 10.1007/s11046-018-0305-2
– ident: e_1_2_8_6_1
  doi: 10.3390/jof6010027
– ident: e_1_2_8_4_1
  doi: 10.1016/S1473-3099(18)30103-8
– ident: e_1_2_8_5_1
  doi: 10.3389/fpubh.2018.00078
– ident: e_1_2_8_48_1
  doi: 10.1111/myc.12946
SSID ssj0017918
Score 2.3317647
Snippet Aim Vulvovaginal candidiasis (VVC), is a common fungal infection that remains a global concern. The objectives of this study were molecular identification and...
AimVulvovaginal candidiasis (VVC), is a common fungal infection that remains a global concern. The objectives of this study were molecular identification and...
Vulvovaginal candidiasis (VVC), is a common fungal infection that remains a global concern. The objectives of this study were molecular identification and...
SourceID proquest
crossref
wiley
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 3292
SubjectTerms Antifungal agents
Candida
Candidiasis
Epidemiology
Fluconazole
Fungal infections
Geographical distribution
Iran
Itraconazole
polymerase chain reaction
Species
Susceptibility
Voriconazole
vulvovaginal candidiasis
Title Vulvovaginal candidiasis in Iranian women: Molecular identification and antifungal susceptibility pattern
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjog.15442
https://www.proquest.com/docview/2743763673
https://www.proquest.com/docview/2720925088
Volume 48
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 1341-8076
  databaseCode: DR2
  dateStart: 19970101
  customDbUrl:
  isFulltext: true
  eissn: 1447-0756
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017918
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwEA9jD-KL3-J0ShQffKn0M231ScSvwRTEiQ9CadJkFEc77DrQv967rK1TFMSHQmkvbdrLfSS5-x0hh6ZwOVjywJCJqQw34MqIE86MQDpgr4LAEgKzkfu37Hrg9p68pxY5rXNhZvgQzYIbSobW1yjgMS_mhTwf4rKIi_rXcpieTt030FGIuqnT4EBLI-Auq1CFdBRP3fKrLfp0MOfdVG1nLpfJc93DWXjJy3E54cfi_Rt44z8_YYUsVf4nPZsNmFXSktkaWehXO-zrJH0sR9N8GutqWVRg0guMoCItaJrRGzBsMJyohm04of26tC5NkyroSPOZQis44AJoEnhKURY6eEbH4b7RsYb0zDbI4PLi4fzaqMoxGMLxXPDDuc8Vs4TncS_xlRUD9904jJU0HaF81A2h9Ll0WOKZKvAdLP6nkjDgFgsUuJWbpJ3lmdwi1OS-7XqmnTDkD2c8YVzAYzlz_Th0VIcc1YyJRIVVjiUzRlEzZ8mHkf51HXLQkI5nAB0_EXVr7kaVjBYRzMdRuzLf6ZD95jZIF26ZxJnMS6SxzdBGJxa6pFn5-0ui3t2VPtn-O-kOWbQxn0LHx3RJe_Jayl3wciZ8Tw_nD2VR-nU
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS-QwFD6Igvriellxdr1E8cGXSqdN01Z8EVHHyyiILr4spUkTGZRWtlNBf73nZNp6wQXxoVDapE17rknO-Q7Apqu4REseOTpzjcMjaZw0k8KJtI_2Koq6SlE2cv9c9K75yU1wMwa7TS7MCB-iXXAjybD6mgScFqTfSnlxS-siHBXwBBc4TyGX6LIFjyLcTZsIh3qaIHdFjStk43iaru-t0auL-dZRtZbm8Af8bcY4CjC5266Gcls9f4Bv_O5HzMJM7YKyvRHPzMGYzudhsl9vsi_A4E91_1g8prZgFlOU94JMVA5KNsjZMdo25ChmkRt2WL-prssGWR13ZEnNsBceeAGVCT6lrEobP2NDcZ_Yg0X1zH_C9eHB1X7PqSsyOMoPOLriMpRGdFUQyCALTTdFBuBpnBrt-sqEpB5iHUrtiyxwTRT6VP_PZHEkuyIy6Fkuwnhe5HoJmCtDjweulwkikBQyE1LhY6XgYRr7pgNbDWUSVcOVU9WM-6SdthS3if11Hdhomz6MMDo-a7TckDepxbRMcEpOClaEfgfW29soYLRrkua6qKiN58Ye-bE4JEvL_78kObk4sie_vt50DaZ6V_2z5Oz4_PQ3THuUXmHDZZZhfPiv0ivo9AzlquXtFxC6_pY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9KC8UXbavi2WpX6YMvKblks9kUX8T2-mGviljpi4TsVzlakqO5FPSvd2YvST-wIH0IhGQ32WQ-d3fmNwBboeYKLbkMrAldwKVyQWGUCKSN0V5JOdSaspHHJ-LglB-dJWcL8LHLhZnjQ_QLbiQZXl-TgNupcbelvDqndRGOCniJJ5mkgL7d7z14FOFu-kQ41NMEuStaXCEfx9N1vWuNblzM246qtzSjZ_CrG-M8wORiu5mpbf3nHnzjYz9iBZ62Lij7NOeZVViw5Rosj9tN9ucw-dlcXlfXhS-YxTTlvSAT1ZOaTUp2iLYNOYp55IYdNu6q67KJaeOOPKkZ9sIDL6AywafUTe3jZ3wo7m829aie5Qs4He39-HwQtBUZAh0nHF1xlSonhjpJVGJSNyyQAXiRFc6GsXYpqYfMpsrGwiShk2lM9f-cyaQaCunQs3wJi2VV2lfAQpVGPAkjI4hASigjlMbHKsHTIovdAD50lMl1C1dOVTMu837aUp3n_tcN4H3fdDrH6PhXo42OvHkrpnWOU3JSsCKNB_Cuv40CRrsmRWmrhtpEYRaRH4tD8rR8-CX50dd9f_L6_5tuwvK33VF-fHjyZR2eRJRd4aNlNmBxdtXYN-jzzNRbz9p_Absa_ho
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vulvovaginal+candidiasis+in+Iranian+women%3A+Molecular+identification+and+antifungal+susceptibility+pattern&rft.jtitle=The+journal+of+obstetrics+and+gynaecology+research&rft.au=Khaksar+Baniasadi%2C+Ali&rft.au=Ayatollahi+Mosavi%2C+Seyyed+Amin&rft.au=Sharifi%2C+Iraj&rft.au=Bamorovat%2C+Mehdi&rft.date=2022-12-01&rft.issn=1341-8076&rft.eissn=1447-0756&rft.volume=48&rft.issue=12&rft.spage=3292&rft.epage=3303&rft_id=info:doi/10.1111%2Fjog.15442&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_jog_15442
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1341-8076&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1341-8076&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1341-8076&client=summon